“Our findings indicate that each year, reasonably healthy women spend billions
of dollars on drugs in the hope of preventing heart attacks, but that scientific
evidence supporting their hope does not exist,” …
“When the FDA says ‘we think you ought to consider’ something, that should not
be viewed as a suggestion, but as a mandate,” he explains. “Companies are
foolish if they don’t follow what the FDA has suggested.” A biotech takes on
significant and unnecessary risk if it doesn’t follow an FDA suggestion or
proactively address the FDA’s concerns. …
While genetic engineering is common in the food industry, a number of biotechs
are also using the science to produce hormones and antibodies that can be used
therapeutically. …
Fortunately, AGBIOS, a Canadian company with vast experience in public safety
and risk assessment of biotechnology products, has taken upon itself to deliver
an online repository of knowledge about these important organisms. …
AƦČ章Ɛ䁈Ɛ
This year’s report from the Attorney General’s Office showed that Vermont
doctors received $3.1 million in gifts and donations from the pharmaceutical and
medical industry — an increase of 33 percent over the previous year. …
Again, patients showed lower brain volume and larger fluid-filled spaces on MRI
scans, with no differences between those who began treatment either a few months
or more than 1,year after an initial period of psychosis. …
“Our new study is very promising because it suggests that we could alleviate
pain by targeting the cannabinoid receptor CB2 without causing the kinds of
side-effects we associate with people using cannabis itself.”
…
That’s bad news for the companies that make leading atypicals–Johnson & Johnson Risperdal, Eli Lilly (Zyprexa), Bristol-Myers Squibb (Abilify),Pfizer (Geodon), AstraZeneca(Seroquel). Prescription rates for these meds have enjoyed a
strong growth curve, increasing more than fivefold among children over the past
15 years. …
The lawsuit was filed for the Attorney General’s Office in the 1st Judicial
District Court in Santa Fe by a Houston civil litigation firm, Bailey Perrin
Bailey, which specializes in lawsuits over the new generation of antipsychotic
drugs known as atypical antipsychotics. …
“They are interested in pharmacogenetic purposes to do case control studies of
adverse drug reactions,” said John Novembre, a co-author of the study published
in Nature. …